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Summary
Background: Acyl carrier protein (ACP) is a fundamental 
component of fatty acid biosynthesis in which the fatty acid 
chain is elongated by the fatty acid synthetase system while 
attached to the 4’-phosphopantetheine prosthetic group (4’-
PP) of ACP. Activation of ACP is mediated by holo-acyl car-
rier protein synthase (ACPS) when ACPS transfers the 4’-PP 
moiety from coenzyme A (CoA) to Ser36 of apo-ACP. Both 
ACP and ACPS have been identifi ed as essential for E. coli 
viability and potential targets for development of antibiotics.
Results: The solution structure of B. subtilis ACP (9 kDa) has 
been determined using two-dimensional and three-dimen-
sional heteronuclear NMR spectroscopy. A total of 22 struc-
tures were calculated by means of hybrid distance geometry-
simulated annealing using a total of 1050 experimental NMR 
restraints. The atomic rmsd about the mean coordinate posi-
tions for the 22 structures is 0.45 ± 0.08 Å for the backbone 
atoms and 0.93 ± 0.07 Å for all atoms. The overall ACP struc-
ture consists of a four α-helical  bundle in which 4’-PP is at-
tached to the conserved Ser36 that is located in a helix II.
Conclusions: Structural data were collected for both the 
apo and holo forms of ACP that suggest that the two forms 
of ACP are essentially identical. Comparison of the published 
structures for E. coli ACP and actinorhodin polyketide syn-
thase acyl carrier protein (act apo-ACP) from Streptomyces 
coelicolor A3(2) with B. subtilis ACP indicates similar second-
ary structure elements but an extremely large rmsd between 
the three ACP structures (>4.3 Å). The structural difference 
between B. subtilis ACP and both E. coli and act apo-ACP is 
not attributed to an inherent difference in the proteins, but is 
probably a result of a limitation in the methodology available 
for the analysis for E. coli and act apo-ACP. Comparison of 
the structure of free ACP with the bound form of ACP in the 
ACP-ACPS complex reveals a displacement of helix II in the 
vicinity of Ser36. The induced perturbation of ACP by ACPS 
positions Ser36 proximal to coenzyme A and aligns the di-
pole of helix II to initiate transfer of 4’-PP to ACP. 
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Introduction
The biosynthesis of fatty acids consists of a series of re-
actions that are catalyzed by specifi c enzymes [1]. The or-
ganization of the enzymatic activity is signifi cantly different 
between eukaryotic cells and prokaryotic and plant cells. In 
eukaryotic cells, large multifunctional enzymes exist with 
distinct domains that are associated with a particular func-
tion. Conversely, in prokaryotic and plant cells, the various 
enzymatic activities are associated with individual proteins 
that are loosely associated with each other. Acyl carrier pro-
tein (ACP) is a discrete, small acidic protein (9 kDa) in pro-
karyotic and plant cells that plays an essential role in fatty 
acid biosynthesis, whereas, in animal tissue, ACP is a sub-
unit of the fatty acid synthetase (FAS). ACP is the carrier of 
fatty acids during fatty acid biosynthesis and is responsible 
for acyl group activation [1, 2 and 3].
A unique feature of ACP is the presence of the 4’phos-
phopantetheine (4’-PP) prosthetic group. The 4’-PP moiety 
is attached through a phosphodiester linkage to a specifi c 
conserved serine residue found in all ACPs. ACP exists in 
both an active (holo) and inactive (apo) form in which acti-
vation of ACP is mediated by holo-acyl carrier protein syn-
thase (ACPS). ACPS transfers the 4’-PP moiety from coen-
zyme A to Ser36 of apo-ACP to produce holo-ACP and 3’, 
5’-ADP in a Mg+2-dependent reaction. During biosynthesis 
of a long-chain fatty acid, the fatty acid chain is attached to 
ACP via a thioester linkage to the terminal cysteamine thiol 
of the 4’-PP prosthetic group, where it is then elongated by 
the FAS system. A potential function of the 4’-PP prosthetic 
group is to act as a tether that serves to transfer the grow-
ing fatty acid chains between the various enzymes or ac-
tive sites in the FAS system [4].
ACP is a central component of and plays a fundamen-
tal role in fatty acid and other biosynthetic pathways that re-
quire acyl transfer steps [5, 6, 7, 8 and 9]. The activation of 
ACP by ACPS is critical to this function in which both ACP 
and ACPS were identifi ed as being essential for the viabil-
ity of E. coli [10 and 11]. Furthermore, both ACP and ACPS 
are viable targets for a drug discovery program, since the 
enzymes are essentially unique to prokaryotic cells. This 
is made further evident by previous efforts to determine 
the structures for E. coli ACP and act apo-ACP prior to the 
structure determination of B. subtilis ACP reported herein 
[12, 13, 14 and 15]. Since the activation of ACP is mediated 
by its interaction with ACPS, interfering with either the ac-
tivity of ACPS or the binding interaction of ACPS with ACP 
may prove to be a valuable approach for developing novel 
antibiotics. Toward this goal, we present the NMR reso-
nance assignments and the determination of the solution 
conformation of B. subtilis ACP.
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Results and Discussion
Secondary Structure Analysis and Structure 
Determination
The regular secondary structure elements of ACP were 
identifi ed through a qualitative analysis of sequential and 
medium- range NOEs obtained from the 15N/13C-edited 
NOESY spectra, NH exchange rates, φ/ψ dihedral torsion 
angles from Talos [16], and the 13Cα and 13Cβ secondary 
chemical shifts [17]. The secondary structure of B. subtilis 
ACP is composed of four helical regions that correspond 
to residues A1-R14 (αI), S36-F50 (αII), D56-E60 (αIII), and 
G66-Q75 (aVI). Three loop regions of various lengths con-
nect the four helices.
The calculated three-dimensional structure of B. subtilis 
ACP is well defi ned by 1050 distance restraints, 54 hydro-
gen bond restraints, and 92 torsion angle restraints. The α-
helical  regions of the calculated structure are similar to the 
predicted secondary structure elements. Figure 1a shows 
the best-fi t superposition of the Ca traces for the fi nal en-
semble of 22 structures, illustrating the consistency within 
the a helix “framework” and variability of one long (20 resi-
dues) and two short interhelix loops (3 and 6 residues). The 
ribbon diagram of the ensemble average-minimized struc-
ture is shown in Figure 1b. The NMR structure is well de-
fi ned, as evident by the atomic rmsd of the 22 simulated 
annealing structures about the mean coordinate positions 
where the backbone and all atoms’ rmsd are 0.45 ± 0.08 Å 
and 0.93 ± 0.07 Å, respectively. For residues that are only 
in secondary structure regions, the backbone and all at-
oms’ rmsd are 0.35 ± 0.08 Å and 0.85 ± 0.06 Å, respec-
tively. The B. subtilis ACP NMR structure is consistent with 
a high-quality structure based on PROCHECK and Ram-
achandran analysis [18 and 19]. A Ramachandran plot of 
the average-minimized structure shows a total of 83.1% of 
the residues in the most favored region, 12.7% in the addi-
tional allowed region, and 2.8% in the generously allowed 
regions, with only 1 residue (Val17) in a disallowed region. 
Val17 is a member of the twist turn, which is located in the 
long loop between helices I and II. PROCHECK analysis 
indicates an overall G factor of -0.23 and only two bad con-
tacts. Table 1 also lists other relevant refi nement statistics, 
all of which indicate reasonable geometry and energetics 
for the fi nal ensemble and average-minimized structures. 
Description of the B. subtilis ACP NMR-Derived 
Structures
The solution structure of the B. subtilis ACP consists of a 
four α-helical  bundle where helices I (D2-L15, colored red 
in Figures 1a and 1b), II (S36-E49, colored green in Fig-
ures 1a and 1b), and IV (V65-Q75, colored magenta in 
Figures 1a and 1b) are essentially parallel and have an 
approximately equal length (11-14 residues) with an up-
down-down topology. Helix III (D56-K61, colored orange in 
Figures 1a and 1b) is shorter relative to the other helices 
and packs effectively perpendicular to the helical bundle. 
Three different length loops (colored blue) connect the four 
helices. A long loop (G16-D35) connects helix I to helix II. A 
shorter loop (F50-S55) connects helix II to III, and a 3-res-
idue loop (I62-T64) links helix III and VI. The a helices I, II, 
and IV of B. subtilis ACP have an amphipathic character. 
Many of the long-range NOEs involved in packing of the 
helical bundle occur between the hydrophobic side chains, 
corresponding to residues L4, V7, I11, and L15 in a I; V39, 
V40, L42, V43, and L46 in a II; and V65, A68, V69, and I72 
in a VI. These residues form the hydrophobic core of ACP, 
in which the side chain interactions between these residues 
stabilize the global fold of the protein. The B. subtilis ACP 
has two phenylalanines, F28 and F50, that are located in 
the second half of the fi rst long loop and correspond to the 
fi rst residue of the second loop, respectively. In the aver-
age-minimized structure, both F28 and F50 interact with 
the hydrophobic core that is formed by the packing of the 
helical bundle. F28 and F50 are in close contact with res-
idues I10, I11, and L15 in a I; V39, L42, and L46 in a II; 
and V65 and I72 in a VI, which is consistent with the ex-
perimental long-range NOEs. Conversely, the side chains 
of many hydrophilic residues in the helical bundle are sol-
vent exposed. These residues correspond to E5, T8, K9, 
and D13 in a I; D38, E41, E45, E47, and D48 in a II; and 
D67, N70, Y71, N74, and Q75 in a IV.
Relative to the other helices, α III is highly hydrophilic 
and contains only 1 hydrophobic residue, A59. Given 
its high rmsd relative to the helix bundle, a III could be 
Figure 1. Solution Structure of B. subtilis ACP
(a). The best-fi t superposition of the Ca traces of the 22 members of 
the fi nal ensemble of NMR-derived structures of B. subtilis ACP.
(b) Ribbon diagram of the averaged and minimized NMR structure 
of B. subtilis ACP. For (a) and (b), helixes I-VI are colored red, green, 
orange, and magenta, respectively. The crossover loops are colored 
blue.
(c) Residues that exhibit two distinct sets of 15N/NH chemical shifts 
associated with the apo and holo forms of B. subtilis ACP are colored 
red, and S36 is colored magenta.
(d) The hydrophobic pocket composed of residues F28, V39, V40, 
L42, V43, L46, and V65 (blue) is illustrated. The surface correspond-
ing to S36, which is proximal to the hydrophobic pocket, is colored 
magenta
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viewed as part as of the loop region that connects helix II 
and IV. In fact, this short helix is missing in the structures 
of the other members of the ACP family [12 and 13]. In the 
B. subtilis ACP structure, long-range NOEs that are consis-
tent with the ACP three-dimensional structure indicate that 
A59 is in close contact with residues V40 in a II and V65 
in a VI. This indicates that A59 participates in a hydropho-
bic interaction with the helical bundle. Additionally, D58 is in 
close proximity with Y71 from a VI, where the phenolic hy-
droxyl might form a hydrogen bond with the carboxyl side 
chain from D58. These interactions defi ne the close contact 
of helix III with both helices II and VI and determine its per-
pendicular orientation (~60°).
The long loop between helices I and II is composed of 
20 residues (G16-D35) and starts with a distorted short turn 
(G16-A20) that is defi ned by numerous medium-range (i,i+2 
and i,i+3) interactions. The remainder of this long loop is not 
well defi ned and effectively adopts an unstructured random 
conformation that is a result of a defi ciency of medium- and 
long-range NOE restraints. The lack of a defi ned structure 
for most of the long loop region is also made apparent by 
an absence of slow-exchanging amide protons. As a result, 
the rmsd for this loop region is much higher (0.57 Å and 
1.25 Å) for backbone and all atoms, respectively, than the 
rmsd for secondary structure regions (0.30 Å and 0.80 Å). 
The long loop has an amphipathic characteristic that con-
tains 10 hydrophobic and 10 hydrophilic residues. The B. 
subtilis ACP structure indicates that most of the hydrophilic 
residues are exposed to the solvent, while most of the hy-
drophobic residues are orientated toward the central hydro-
phobic helical core. In addition to the long-range interac-
tions described previously for F28, a number of long-range 
NOEs were observed between the hydrophobic side chains 
from the long loop region and both the C-terminal end of 
helix I and the N-terminal end of helix VI.
Holo and Apo Forms of B. subtilis ACP
The NMR sample used for the B. subtilis ACP structure 
determination consists of an approximate 60:40 mixture 
of the holo and apo forms, respectively. The 4’-PP moi-
ety from CoA is attached to the conserved S36 on ACP, 
as evident by the presence of two distinct sets of chem-
ical shifts in the 1H-15N HSQC spectrum for the N-termi-
nal region of helix II that is in the vicinity of S36 (Figure 2). 
Figure 2a illustrates the distinct chemical shifts that are 
observed in the 1H-15N HSQC for the residues in the vi-
cinity of the 4’-PP prosthetic group. For example, the am-
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ide proton and 15N chemical shifts of S36 are at 8.76 ppm 
and 112.7 ppm, respectively, for holo-ACP compared to 
8.47 ppm and 114.0 ppm for apo-ACP. Similarly, L37 ex-
hibits amide proton and 15N chemical shifts at 7.99 ppm 
and 124.4 ppm for holo-ACP, compared to 8.03 ppm and 
123.3 ppm for apo-ACP. D38 exhibits amide proton and 
15N chemical shifts at 8.34 ppm and 120.0 ppm for holo-
ACP, compared to 8.17 ppm and 119.7 ppm for apo-ACP. 
The residues that incur a chemical shift change as a func-
tion of the holo and apo forms of ACP are colored in Fig-
ure 1c, where S36 is colored magenta, and the other per-
turbed residues are colored red. 
Despite the observed chemical shift perturbations in the 
1H-15N HSQC spectra between the holo and apo forms of 
ACP, the 13C and 1H side chain chemical shifts for these 
residues are essentially unchanged. This was apparent from 
the HSQC-based triple-resonance experiments, in which a 
doubling of peaks was observed based on the different am-
ide proton and 15N resonances for the apo and holo forms, 
but the remainder of the crosspeaks were identical or nearly 
identical. Additionally, the 15N-edited NOESY spectra did not 
show any distinct NOE patterns for holo- and apo-ACP resi-
dues (Figure 2b). This was also the case for S36, which has 
the largest chemical shift difference in the 1H-15N HSQC 
Figure 2. 2-D 1H-15N HSQC and 3-D 15N-edited NOESY-HMQC Spectrum of Apo and Holo Forms of B. subtilis ACP
(a) An expansion of the 2-D 1H-15N HSQC spectrum, illustrating residues that exhibit distinct 15N/NH chemical shifts in the apo and holo forms of 
B. subtilis ACP.
(b) Composite of amide strips taken from the 3-D 15N-edited NOESY-HMQC spectrum of B. subtilis ACP, corresponding to residues S36-V40 that 
exhibit distinct 15N/NH chemical shifts in the apo and holo forms of B. subtilis ACP. For clarity, some of the crosspeak assignments are labeled. 
HDO and cross-peaks that are attributed to other residues are labeled with an asterisk
Figure 3. Sequence Alignment of E. coli and act apo-
ACP with B. subtilis ACPIdentical residue types are 
colored black, and identical residue classes are col-
ored red 
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spectra. For holo-ACP, no additional NOEs were observed 
between the 4’-PP prosthetic group and the protein itself, 
except for the linkage between the 4’-PP prosthetic group 
and S36. These results suggest that the structures of holo-
ACP and apo-ACP are essentially the same and that the 4’-
PP prosthetic group of holo-ACP does not incur any prefer-
ential interactions with the protein. This implies that either 
the 4’-PP prosthetic group is essentially solvent exposed or 
experiences rapid exchange between multiple low- affi nity 
binding interactions with ACP. Because the function of ACP 
is to carry the fatty acid chain as it is elongated by FAS, it is 
not surprising that the 4’-PP prosthetic group is readily ac-
cessible at the protein surface. S36 is located at the top of 
helix II at the surface of the protein, making it readily acces-
sible by ACPS and FAS (Figure 1c). Proximal to S36 is a 
hydrophobic pocket, composed of residues F28, V39, L42, 
V43, L46, and I62, which may be involved in binding the 
acyl chain as it is lengthened (Figure 1d).
The addition of acyl moieties to ACP results in stabiliz-
ing the protein against pH denaturation. There is a direct 
correlation between the degree of protection from pH de-
naturation and the increasing length of the acyl chain [20 
and 21]. Additionally, the binding affi nity of acyl-ACP to oc-
tyl-sepharose based on the length of the acyl chain and the 
lack of affi nity for apo-ACP suggests the presence of an 
acyl chain binding site on ACP [22]. Furthermore, 1D 19F-
1H cross-relaxation and chemical shift perturbation experi-
ments have identifi ed a number of potential ACP residues 
that may be involved in the interaction of the acyl chain or 
a conformational change in ACP that occurs upon acyla-
tion [23 and 24]. Again, the extent of the observed chemical 
shift changes correlates with an increase in the acyl chain 
length. Finally, the X-ray structure of ACP complexed with 
ACPS demonstrates that the 4’-PP prosthetic group is em-
bedded in the hydrophobic pocket of ACP [25]. These re-
sults, taken in total, support the proposition that the growing 
acyl chain that is attached to ACP binds in a hydrophobic 
pocket that is proximal to S36. The affi nity of the acyl chain 
for the hydrophobic pocket increases as a function of in-
creasing chain length. This follows the expected trend that 
as the chain length increases and becomes more hydro-
phobic in nature, there is a greater tendency for the acyl 
chain to avoid the solvent. In the case of the NMR struc-
ture of B. subtilis ACP reported here, only the 4’-PP pros-
thetic group is attached to ACP. This differs from the stud-
ies reported above, excluding the X-ray structure, in which 
the acyl chains contained anywhere from 2 to >10 addi-
tional carbon atoms relative to 4’-PP. The 4’-PP prosthetic 
group itself is not extensively hydrophobic, and, as evident 
from the results described above, increasing the acyl chain 
length has a pronounced effect on hydrophobicity. There-
fore, it is not too surprising that the NMR structure does not 
identify that the 4’-PP binds exclusively into the hydropho-
bic pocket, and that the apo- and holo-ACP structures are 
essentially identical.
Comparison of the B. subtilis ACP Structure with the 
E. coli ACP and act apo-ACP Structures
NMR structures for E. coli ACP and act apo-ACP were re-
ported in the literature [12, 13 and 15] prior to initiation of 
our efforts on the structure determination of B. subtilis ACP. 
Amino acid sequence alignments indicate that E. coli ACP 
is highly homologous to B. subtilis ACP, where 53 of 76 res-
idues correspond to identical residue classes (70%) (Fig-
ure 3). Similarly, comparison of act apo-ACP with B. subtilis 
ACP indicates that 38 of 76 residues correspond to identi-
cal residue classes (50%) (Figure 3). The overall sequence 
homology suggests that the three proteins should have a 
similar global fold (Figures 4a and 4b). 
Comparison of the published structures for E. coli ACP 
(PDB ID:1ACP) and act apo-ACP (PDB ID:2AF8) with B. 
subtilis ACP indicate that the three proteins have similar 
secondary structure elements, where the α-helical con-
tent corresponds to 51%, 49%, and 60% for E. coli, act 
apo-, and B. subtilis ACP, respectively. The overall ACP 
structure consists of a four a-helical bundle where three 
a helices are relatively long (6-15 residues) and one he-
lix is short (0-6 residues). Despite the similarity in the 
amino acid sequence and secondary structure features, 
the global fold for the three ACP structures is distinct. This 
is made readily apparent by the superposition of the av-
erage-minimized structures for E. coli ACP and act apo-
ACP with B. subtilis ACP (Figures 4a and 4b). The atomic 
rmsd of the Ca atoms between E. coli and B. subtilis ACP 
for the 53 homologous residues is 4.63 Å. The compari-
son improves to 3.82 Å for similar secondary structure re-
gions. Similarly, the atomic rmsd of the Ca atoms between 
act apo- and B. subtilis ACP for the 38 homologous resi-
dues is 4.39 Å. Again, an improvement to 2.66 Å occurs 
when only similar secondary structure regions are used in 
the comparison. Moreover, the rmsd between the Ca at-
oms for the 36 identical residue classes between E. coli 
and act apo is 5.60 Å, which is much higher than the de-
viations between these two proteins and B. subtilis ACP. 
These large rmsd indicate that the three ACP structures 
are relatively unique.
The observed large rmsd between the three ACPS 
structures are located mainly in the short a helix III and the 
long loop region between helix I and II. The short a helix III 
is not present in the average-minimized act apo-ACP struc-
ture. Also, in some models, the short a III is absent from the 
ensemble of structures for both E. coli and act apo-ACP. 
Some of the observed differences between the B. sub-
tilis ACP structure and both the E. coli and act apo-ACP 
structures result from unusual features of the E. coli and 
act apo-ACP structures. An example is the presence of a 
large kink in a helix I for E. coli ACP that results in this he-
lix being extremely distorted. An additional factor contribut-
ing to the difference between B. subtilis ACP structure and 
both the E. coli and act apo-ACP is attributed to the rela-
tive displacement of the helical regions. The observation of 
distinct structures for the three ACP proteins is unexpected 
given the reasonable sequence homology and the obvious 
fact that the proteins are functionally identical. During the 
time frame that the three structures for ACP have been de-
termined, there have been advances in NMR methodology 
in its application in solving solution structures of protein. 
Therefore, a potential source for the structural difference 
may have resulted from limitations in the structure deter-
mination process for the early  ACP structures instead of 
an intrinsic difference in the proteins. Furthermore, physi-
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cal behavior encountered with the previous ACP structures 
that were not a factor in the B. subtilis ACP structure would 
have only exasperated the methodology limitations for the 
earlier structures.
The NMR analysis of the E. coli ACP structure sug-
gests the existence of equilibrium between multiple con-
formers [13 and 14]. Additional technical diffi culties were 
reported in the structure determination of spinach ACP 
and the nodulation protein NodF from Rhizobium legu-
minosarum, in which both proteins share homology with 
ACP [26 and 27]. In both cases, only low-resolution struc-
tures were determined, because of the lack of experimen-
tal restraints and the fact that three-dimensional structures 
were not released to the Protein Data Bank. Nevertheless, 
the overall fold and secondary structure of spinach ACP 
and the nodulation protein NodF were consistent with the 
E. coli ACP structure. These results clearly suggest an in-
herent technical diffi culty that was encountered with the 
previous ACP structures that was not a factor in the B. 
subtilis ACP structure.
The structure determinations for both E. coli and act 
apo-ACP were limited to homonuclear two-dimensional 
NMR experiments. In the case of the B. subtilis ACP struc-
ture, we were able to take full advantage of the current 
state of multidimensional heteronuclear NMR methodolo-
gies utilizing 15N/13C isotope-enriched B. subtilis ACP [28]. 
This approach was not readily accessible for the determi-
nation of the E. coli and act apo-ACP structures. Further 
complicating the inherent limitations in the analysis of 2-D 
NMR data is the helical nature of ACP, causing the NMR 
spectra to exhibit relatively narrow chemical shift disper-
sion. As a result of these relative limitations, the structures 
for E. coli and act apo- ACP were based on a minimal num-
ber of distance restraints, especially long-range distance 
restraints, compared to those used in the determination of 
the B. subtilis ACP structure. The E. coli ACP (77 residues) 
structure was based on a total of 478 distance restraints 
comprising 30 H bond distance restraints; 101 intraresidue 
distance restraints; and 205 sequential, 87 short-range, 
and 55 long-range interresidue distance restraints. The av-
erage number of distance restraints was only 6.2 restraints 
per residue. Similarly, the act apo-ACP (86 residues) struc-
ture was based on a total of 747 distance restraints com-
prising 48 H bond distance restraints; 240 intraresidue dis-
tance restraints; and 235 sequential, 131 short-range, 
and 93 long-range distance restraints. The average num-
ber for act apo-ACP was 8.7 restraints per residue. Con-
versely, the B. subtilis ACP (76 residues) structure reported 
herein was based on a total of 1050 distance restraints, 
with an average of 13.8 restraints per residue, comprising 
54 H bond distance restraints; 337 intraresidue distance 
restraints; and 231 sequential, 188 short-range, and 240 
long-range interresidue restraints. Similarly, the B. subtilis 
ACP structure was based on more φ and ψ dihedral angle 
restraints relative to both E. coli and act apo-ACP. A total 
of 96 φ and ψ dihedral angle restraints were used for the 
B. subtilis ACP structure, compared to 54 and 63 for the E. 
coli and act apo-ACP structures, respectively. In addition, 
the B. subtilis ACP structure was refi ned using both Ca/
Cß chemical shift restraints [29] and a conformational data
base potential [30], which were not available refi nement 
approaches for the E. coli and act apo-ACP structures. 
Clearly, the increase in the number of the restraints for the 
B. subtilis ACP structure was attributed to the utilization of 
13C/15N-labeled ACP in combination with 3-D heteronuclear 
NMR experiments. This approach overcomes most of the 
limitations encountered with the unlabeled ACP samples 
and 2-D based NMR experiments.
It has been well-established that the accuracy and pre-
cision of NMR solution structures is correlated with the 
number of structural restraints [31]. In addition to the num-
ber of restraints, the quality of the ACP structures is also 
refl ected by the rmsd between each structure in the en-
semble relative to the average structure. Typically, a high-
resolution NMR structure exhibits a backbone rmsd of <0.5 
Å. As apparent in Table 2, the structures for E. coli and act 
apo-ACP have extremely high rmsd values, suggestive of a 
low-resolution structure, whereas, the B. subtilis ACP struc-
ture reported herein demonstrates rmsd values consistent 
with a high-quality structure. Again, these differences pre-
sumably refl ect the inherent limitations of 2-D homonuclear 
NMR methodologies compared to multidimensional hetero-
nuclear NMR approaches and the resulting increase in the 
number of restraints needed to solve the B. subtilis ACP 
structure. 
Recently, the solution structure of a peptidyl carrier pro-
tein (PCP) was published [32]. PCP has a similar biological 
function to ACP and contains a conserved serine where the 
cofactor 4’-phosphopantetheine is attached. The sequence 
alignment between PCP and ACP indicates a lack of se-
quence homology, with the exception of the site of cofactor 
binding. In addition, the calculated pI values of PCP, E. coli, 
and act apo-ACP are strikingly different. However, PCP has 
topology and structural features similar to those of ACP, 
where the PCP structure is composed of a distorted four α-
helical  bundle with an extended loop between the fi rst two 
helices. The similarity between the PCP and B. subtilis ACP 
structures supports the general belief that function is a pri-
mary factor in defi ning a protein’s structure. Therefore, the 
observed structural difference between B. subtilis ACP with 
both E. coli and act apo-ACP appears to be attributed to 
limitations in the available NMR methodology for the E. coli 
and act apo-ACP structures, which was further exasper-
ated by the physical behavior of both E. coli and act apo-
ACP. Given the high-sequence homology and the identical 
functions, it appears unlikely that the observed differ-
ences between the three ACP structures reflect an in-
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herent difference in the structure of these proteins. The 
accuracy and precision of the B. subtilis ACP structure 
is supported by the high-quality structural and energetic 
statistics and the relatively low atomic rms differences 
reported in Table 1. Further support for the reliability of 
the B. subtilis ACP structure is the fact that the B. subti-
lis ACP was useful in aiding in the solution of the X-ray 
structure of ACP in the B. subtilis ACP-ACPS complex 
[25]. Similar attempts to use the E. coli ACP structure to 
assist the X-ray structure refinement of the ACP-ACPs 
complex was not successful, presumably a result of the 
large difference in the E. coli ACP structure.
Comparison of the Structures of Free B. subtilis 
ACP with ACP in the ACP-ACPS Complex
An overlay of the ribbon diagrams and Ca traces of the NMR 
structure for the free B. subtilis ACP and the X-ray structure 
of ACP from the B. subtilis ACP-ACPS complex with bound 
CoA [25] is illustrated in Figure 4c. The backbone atomic 
rms difference between the free and bound forms of ACP 
is 2.11 Å and 1.57 Å for all backbone atoms and regions of 
defi ned secondary structure, respectively. Figure 5b illus-
trates the Ca deviations on a per residue basis (A1-Q73) 
between the free and bound forms of ACP. The observed 
Ca deviations range from 0.43 to 4.87 Å, with signifi cant dif-
ferences localized in the fi rst long loop and the N terminus
of helix II. The long loop in the free ACP structure is less 
defi ned and unstructured, a result of the limited number of 
medium- and long-range distance restraints. Conversely, 
for ACP in the ACP-ACPS complex, a short a helix is ob-
served for residues F28-D31 in this long loop. This is the 
fi rst example of a helical conformation within the long loop 
region for ACP, suggesting a decrease in fl exibility in the 
ACP-ACPS complex. Comparison of the three long heli-
ces between the free and bound ACP structures indicates 
that helix VI is shorter in the ACP-ACPS complex (V65-
Y71, 7 residues) than in the free form (V65-Q75, 11 resi-
dues). The C terminus for ACP in the ACP-ACPS complex 
appears to exhibit an increase in fl exibility that is suggested 
by the shorter helix and the missing electronic densities for 
the last 3 residues (N74-Q76). 
Figure 4. Overlays of the Ribbon Diagrams of B. subtilis ACP with the 
E. coli, act apo, and X-ray ACP Structures
(a) B. subtilis ACP (red) and E. coli ACP (green).
(b) B. subtilis ACP (red) and act apo-ACP (blue).
(c) Free ACP NMR (red) and X-ray ACP in the ACP-ACPS complex 
(turquoise) 
Figure 5. Structural Differences Between the Free and Bound Forms 
of B. subtilis ACP
(a) The best-fi t superposition of the Ca atoms of helix II of free ACP 
(blue) and bound ACP (red) in the ACP-ACPS complex. The ribbons 
(pink) are part of helices I, II, and IV from ACPS in the ACP-ACPS 
complex. Part of the hydrophobic contacts in the ACP-ACPS complex 
involve L37 from ACP with I15, M18, F25, and F54 from ACPS. S36 
from ACP is displaced and closer to E58 from ACPS in the ACP-ACPS 
complex. S36 in the free ACP structure is 3.6 Å further away from E58 
of ACPS in the ACP-ACPS complex.
(b) Ca deviation between the free B. subtilis ACP structure and 
the ACP structure in the ACP-ACPS complex as a function of residue 
number 
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The X-ray structure of ACP in the ACP-ACPS complex 
[25] indicates that the major interactions between holo-ACP 
and ACPS are predominately hydrophilic in nature and oc-
curs between helix I of ACPS and helix II of ACP. A key salt 
bridge interaction occurs between the side chain carboxyl 
of both D35 and D38 in ACP and the side chain guanido 
group of R14 from ACPS. This key salt bridge is in the vi-
cinity of S36 from ACP, which is the location of the attach-
ment of 4’-PP from CoA to ACP by ACPS. Two additional 
salt bridges, involving residues E41 from ACP and R21 
from ACPS and D48 from ACP and both E22 and R24 from 
ACPS, respectively, are present in the ACP-ACPS inter-
face. The ACP-ACPS binding interaction is additionally sta-
bilized by two hydrophobic contacts, in which L37 and M44 
from ACP protrude into hydrophobic pockets on ACPS, as 
shown in Figure 5a. L37 and M44 from ACP extend into the 
ACPS pockets formed by residues M18, F25, F54, and I15 
and residues F25, R28, and Q22, respectively. The effect 
of these interactions between ACP and ACPS is the rel-
ative displacement of helix II between the bound ( Figure 
5, red) and free ( Figure 5, blue) forms of ACP, where he-
lix II is forced closer to ACPS in the ACP-ACPS complex. 
Moreover, the displacement of the N-terminal end of helix II 
probably allows for S36 of ACP to be pulled into the ACPS 
active site for the attachment of 4’-PP from CoA. E58 is a 
highly conserved residue in ACPS that is involved in coor-
dinating the calcium that is bound to CoA. The side chain 
for S36 from ACP is in close contact with the side chain 
of E58 from ACPS in the ACP-ACPS complex. The close 
proximity of S36 from ACP to E58 from ACPS is probably 
required for the transfer of the 4’-PP moiety from CoA to 
ACP. Superimposing the free ACP structure on the bound 
ACP structure in the ACP-ACPS complex indicated that the 
side chain for S36 from free ACP is ~3.6 Å further from the 
E58 side chain of ACPS than in the complex. In the ACP-
ACPS complex containing bound CoA, the dipole of helix 
II in ACP is pointing toward the pyrophosphate moiety of 
CoA, which orients S36 near the ß-phosphate of CoA and 
an adjacent water molecule [25]. This orientation of helix 
II presumably initiates the transfer of the 4’-PP from CoA 
to ACP. This then implies that the reorganization of helix 
II from ACP upon complex formation with ACPS is a nec-
essary component of the mechanism to transfer the 4’-PP 
moiety from CoA to ACP.
Biological Implications
Acyl carrier protein (ACP) is an essential component in the 
biosynthesis of fatty acids and other biosynthetic pathways 
that require acyl transfer steps. The function of ACP is to 
carry the fatty acid chain as it is elongated by FAS [1, 2 and 
3]. ACP is converted to its active holo form by holo-acyl car-
ier protein synthase (ACPS) with the transfer of 4’-phospho-
pantetheine from coenzyme A to a conserved serine (S36) 
on ACP. The extension of the fatty acid chain then occurs 
through a linkage to the terminal thiol of 4’-PP attached to 
ACP. ACP and ACPS have been demonstrated to be critical 
to the viability of E. coli [10 and 11], suggesting that the ac-
tivities of ACP and ACPS are potential targets for the devel-
opment of novel antibiotics. A detailed understanding of the 
structural contribution of ACP and ACPS to the activity of 
both proteins is fundamental to a drug design program.
Comparison of the B. subtilis ACP structure with both 
the E. coli and act apo-ACP structures indicates a signif-
icant discrepancy between the three ACP structures. Be-
cause of the identical function and high-sequence homol-
ogy between the proteins, we do not believe that there is 
an inherent difference in the ACP structures. Instead, the 
evidence suggests that the discrepancy is a result of tech-
nical diffi culties combined with the inherent limitations of 
the NMR methodologies available to determine the E. coli 
and act apo-ACP structures. This was not an issue in the 
structure determination of B. subtillis ACP. The application 
of NMR to solve pro-tein structures has continued to evolve 
during the time period in which the original ACP structures 
were determined [28]. The utilization of the current state of 
multidimensional heteronuclear NMR techniques in con-
junction with 13C and 15N isotope enrichment permitted the 
determination of a high-resolution structure for B. subtilis 
ACP, as evident by the structural, energetic, and rmsd sta-
tistics (Table 1). We believe that the high-quality B. subti-
lis ACP structure provides an accurate description of the 
structure of ACP.
Comparison of the free ACP structure with the structure 
of ACP in the ACP-ACPS complex, and comparison of the 
apo-ACP structure with the holo-ACP structure may pro-
vide some insight into the mechanism of ACP activation by 
ACPS. The addition of 4’-PP to ACP does not result in any 
observable difference in the structure of the apo and holo 
forms of the protein. Furthermore, there is no evidence for 
any interaction between 4’-PP and ACP, except for the at-
tachment at S36. This implies that 4’-PP in ACP is read-
ily accessible by FAS for elongation of the fatty acid chain. 
Proximal to S36 is a hydrophobic pocket that may be in-
volved in binding the acyl chain as it is lengthened and be-
comes more hydrophobic (Figure 1d). The lack of a struc-
tural difference between holo- and apo-ACP also suggests 
that the dissociation of holo-ACP from the ACP-ACPS com-
plex is not facilitated by a structural change in ACP that is 
induced by the attachment of 4’-PP. Nevertheless, ACPS 
does induce a signifi cant perturbation in the ACP struc-
ture upon complex formation. The result is a displacement 
of helix II and the appropriate positioning of S36 from ACP 
to enable the transfer of 4’-PP from CoA to ACP. S36 from 
ACP is effectively drawn into the ACPS structure into close 
proximity to CoA in ACPS, with the alignment of the helix 
II dipole with the S36-4’-PP attachment point initiating the 
transfer [25]. After transfer of the 4’-PP moiety from ACPS 
to ACP occurs, dissociation of the ACP-ACPS complex is 
probably facilitated by relaxation of the bound structure of 
ACP to its free structure conformation.
Experimental Procedures
B. subtilis ACP Sample Preparation
The uniform 15N/13C-labeled B. subtilis ACP (81 residues) was cloned 
into a pGEX-6P-1 vector and expressed in E. coli strain BL21DE3 
(pLysS). Cells were grown at 37°C on minimal medium containing 
[15N] ammonium sulfate and [U-13C] glucose. For purifi cation, 20 g of 
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the above cell pellet was resuspended in 300 ml breaking buffer con-
sisting of 50 mM Tris-Cl (pH 8.0), 300 mM NaCl, 10 mM MgCl2, and 
2 mM freshly prepared MnCl2. Protease inhibitor tablets (Boehringer 
Mannheim GmbH), RNaseH and DnaseI, (Sigma Chemical Com-
pany) were added to the solution to prevent protease activity and to 
decrease viscosity of the solution. The cells were lysed by three pas-
sages through a microfl uidizer and centrifuged at 15,000 × g for 20 
min at 4°C to remove the cell debris. Glutathione sepharose 4B resin 
(Amersham Pharmacia Biotech) equilibrated with the same break-
ing buffer was added to the clear supernatent. The mixture was incu-
bated at 4°C for 1 hr prior to packing the resin into a suitable column. 
The column was washed, and the GST-ACP was eluted with a buffer 
containing 50 mM Tris-Cl (pH 8.0), 10 mM MgCl2, 5 mM DTT, and 60 
mM reduced glutathione. The resulting GST-ACP solution was dia-
lyzed overnight against 50 mM Tris-Cl (pH 8.0), 150 mM NaCl, 1 mM 
EDTA, and 1 mM DTT. The fusion protein was cleaved with Prescis-
sion Protease (Amersham Pharmacia Biotech) at room temperature 
for 3 hr at a ratio of 1 U enzyme per 500 μg protein. The resulting 
protein mixture was loaded on a MonoQ HR16/10 column (Amer-
sham Pharmacia Biotech), and the ACP protein was eluted with a 
NaCl gradient. ACP containing fractions were pooled and loaded on 
a TSK G2000 size exclusion column prior to the NMR sample prep-
aration.
NMR Data Collection and Assignments
The NMR sample is a mixture of 15N/13C-double-labeled apo- and 
holo-ACP in 50 mM Bis-Tris (pH 6.4), 100 mM NaCl, 10 mM MgCl2, 
and 10 mM DTT with 0.02% NaN3 in 5% D2O/95% H2O solution. The 
protein concentration was approximately 1 mM.
All spectra were recorded at 25°C on a Varian Unity+ 600 spec-
trometer equipped with a triple-resonance 1H/13C/15N probe and an 
actively shielded z gradient-pulsed fi eld accessories. Two-dimensional 
1H-15N HSQC and all HSQC-based 3-D 15N-edited NOESY and 3-D 
triple-resonance experiments were recorded with the enhanced-sen-
sitivity-pulsed fi eld gradient approach [33]. This approach provides co-
herence transfer selection both to improve sensitivity and to eliminate 
artifacts as well as for solvent suppression. For the 2-D 1H-15N HSQC 
and the 3-D 15N-edited NOESY experiments, hard 13C 180° pulses 
were applied in the middle of the t1 period to dephase 13C polarization 
during the transfer of magnetization between the proton and the 15N 
nuclei. The simultaneous 15N/13C-edited NOESY experiment with sep-
aration via the carbon and nitrogen of the destination sites was per-
formed for simultaneous identifi cation of NOEs from both amides and 
aliphatic protons [34 and 35].
Data sets were typically processed and displayed on an SGI work-
station with the program packages NMRDraw and NMRPipe [36]. A 
skewed 60° phase-shifted sine-bell function and a single zero-fi lling 
were used in each dimension prior to Fourier transformation. For tri-
ple-resonance 3-D experiments, the time domain was extended by a 
factor of two, prior to zero-fi lling, using froward-backward linear predic-
tion in the 15N (t2) dimension where mirror image linear prediction was 
used for constant-time 1H-13C correlation experiments [37]. The pro-
grams PIPP and STAPP were used for data analysis and semiauto-
matic assignments [38].
The complete sequential and side chain assignments (>95%) 
of the 1H, 15N, and 13C resonances were based on the follow-
ing experiments: CBCA(CO)NNH, HNCACB, C(CC)TOCSY_NNH, 
H(CC)TOCSY_NNH, and HAHB(CBCACO)NN [33 and 39]. Combi-
nation of a 2-D constant time 13C-1H HSQC experiment optimized for 
methyls and a 2-D- methyl relay experiment were used for auxiliary 
methyl assignments of isoleucine, valine, and leucine, as well as me-
thionine residues. Some ambiguous resonances and sequence as-
signments were further confi rmed by sequential NOEs observed in 
the 15N-edited NOESY experiments [40] and simultaneous 15N/13C-
edited NOESY experiments [34 and 35]. A table of chemical shifts 
has been deposited in the RCSB Protein Data Bank (PDB ID code 
1HY8).
Structure Calculations
The NMR solution structure is based on interproton distance restraints 
converted from observed NOEs in both the 15N-edited NOESY [40] 
and simultaneous 15N/13C-edited NOESY experiments [34 and 35]. 
The NOE intensities were classifi ed as either strong (1.8- 2.7 Å), me-
dium (1.8-3.3 Å), or weak (1.8-5.5 Å) restraints. The upper distance 
limits for distances involving methyl protons and nonstereospecifi cally 
assigned methylene and methyl protons were corrected appropriately 
for center averaging [41], and an additional 0.5 Å was added to the up-
per distance limits for NOEs involving methyl protons averaging [42 
and 43]. φ and ψ torsion angle restraints were obtained from 15N, Ha, 
C, and Cß chemical shifts using the TALOS program, in which only 
“good” predictions were used to generate a restraint [16].
The ACP polypeptide chain used for the NMR structural analysis 
contains 81 residues, including 5 nonnative residues (GPLGS) at the N 
terminus. The 5 N-terminal residues were not used in the structure cal-
culation since these residues are essentially unstructured and the pro-
line residue exhibits cis-trans isomerization. The structure of B. subtilis 
ACP was determined from a total of 1050 distance restraints compris-
ing 337 intraresidue, 231 sequential, 188 medium, and 240 long- range 
distance restraints; 54 hydrogen bond restraints; and 92 torsion angles 
constraints comprised of 46 φ and 46 ψ dihedral restraints. The hydro-
gen bond restraints were based on the observation of slow-exchang-
ing NH protons monitored by 2-D 1H-15N HSQC spectra collected from 
5 min to 4 hr after dissolving the protein in a D2O solution.
The structures were calculated using the hybrid distance geom-
etry-dynamical-simulated annealing method of Nilges et al. [44], with 
minor modifi cations [45] using the program XPLOR [46], which is 
adapted to incorporate pseudopotential secondary 13Ca/13Cß chem-
ical shift restraints [29] and a conformational database potential [30 
and 47]. The target function that is minimized during constrained min-
imization and simulated annealing comprises only quadratic harmonic 
terms for covalent geometry and secondary 13Ca/13Cß chemical shift 
restraints, square-well quadratic potentials for the experimental dis-
tance and torsion angle restraints, and a quartic van der Waals term 
for nonbonded contacts. All peptide bonds were constrained to be pla-
nar and trans. There were no hydrogen bonding, electrostatic, or 6-12 
Lennard-Jones empirical potential energy terms in the target function. 
A family of 36 embedded substructures was generated using distance 
geometry, followed by simulated annealing, regularization, and refi ne-
ment. An iterative procedure was used to successively introduce an in-
creasing number of NOE distance restraints. A fi nal ensemble of 22 
structures contained no distance restraint violations greater than 0.2 
Å, and no torsion angle restraint violations greater than 2° were ob-
tained.
Structural alignment and atomic rmsd comparison between B. sub-
tilis ACP, E. coli, and act apo-ACP were determined using MolMol [48], 
XPLOR [46], and QUANTA (Molecular Simulations). 
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Accession Numbers
Atomic coordinates and the NMR chemical shift assignments for the 
restrained minimized mean structure of ACP have been deposited in 
the RCSB Protein Data Bank (PDB ID code 1HY8).
